{"id":23,"date":"2012-06-05T14:41:37","date_gmt":"2012-06-05T18:41:37","guid":{"rendered":"https:\/\/www.bu.edu\/bam2012\/?page_id=23"},"modified":"2012-09-04T15:33:03","modified_gmt":"2012-09-04T19:33:03","slug":"agenda","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/bam2012\/agenda\/","title":{"rendered":"Agenda"},"content":{"rendered":"<h1>Agenda<\/h1>\n<h2>14th Annual Boston Angiogenesis Meeting<\/h2>\n<h3>Meeting Chair: Matthew A. Nugent<\/h3>\n<table>\n<tbody>\n<tr>\n<td align=\"right\">8:00<\/td>\n<td>\u2013<\/td>\n<td width=\"72\" align=\"right\">8:45 AM<\/td>\n<td>Registration<\/td>\n<td width=\"120\"><\/td>\n<\/tr>\n<tr>\n<td align=\"right\">8:45<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">8:55 AM<\/td>\n<td>Introduction<\/td>\n<td>Matt Nugent<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">\n<h4>8:55<\/h4>\n<\/td>\n<td>\n<h4>\u2013<\/h4>\n<\/td>\n<td align=\"right\">\n<h4>10:35 AM<\/h4>\n<\/td>\n<td>\n<h4><strong>Session 1:    Molecular Mechanisms<\/strong><\/h4>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td align=\"right\">8:55<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">9:05 AM<\/td>\n<td>Moderator Introduction<\/td>\n<td>Nader Rahimi<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">9:05<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">9:35 AM<\/td>\n<td>Regulation of angiogenesis and tumor growth by thrombospondin-1<\/td>\n<td>Jack Lawler<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">9:35<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">10:05 AM<\/td>\n<td>VEGFR-independent action of VEGF-A<\/td>\n<td>Andrius Kazlauskas<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">10:05<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">10:20 AM<\/td>\n<td>Transcriptional Repression of VEGF by ZNF24: Mechanistic Studies and Vascular Consequences<br \/>\nIn Vivo<\/td>\n<td>Di Jia<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">10:20<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">10:35 AM<\/td>\n<td>Transmembrane potential as a morphogenetic signal in vivo<\/td>\n<td>Maria Lobikin<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">\n<h4>10:35<\/h4>\n<\/td>\n<td>\n<h4>\u2013<\/h4>\n<\/td>\n<td align=\"right\">\n<h4>10:55 AM<\/h4>\n<\/td>\n<td>\n<h4><strong><em>BREAK<\/em><\/strong><\/h4>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td align=\"right\">\n<h4>10:55<\/h4>\n<\/td>\n<td>\n<h4>\u2013<\/h4>\n<\/td>\n<td align=\"right\">\n<h4>12:05 PM<\/h4>\n<\/td>\n<td>\n<h4><strong>Session 2:    Pathologic Angiogenesis<\/strong><\/h4>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td align=\"right\">10:55<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">11:05 AM<\/td>\n<td>Moderator Introduction<\/td>\n<td>Harold Dvorak<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">11:05<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">11:35 AM<\/td>\n<td>IGF-1 and ROP<\/td>\n<td>Lois Smith<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">11:35<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">11:50 AM<\/td>\n<td>Antiangiogenic agents targeting the anthrax toxin receptors<\/td>\n<td>Michael Rogers<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">11:50<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">12:05 PM<\/td>\n<td>Innate Immune Mediators of Retinal Neovascularization<\/td>\n<td>Kip Connor<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">\n<h4>12:05<\/h4>\n<\/td>\n<td>\n<h4>\u2013<\/h4>\n<\/td>\n<td align=\"right\">\n<h4>1:05 PM<\/h4>\n<\/td>\n<td>\n<h4><strong><em>LUNCH BREAK<\/em><\/strong><\/h4>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td align=\"right\">\n<h4>1:05<\/h4>\n<\/td>\n<td>\n<h4>\u2013<\/h4>\n<\/td>\n<td align=\"right\">\n<h4>2:35 PM<\/h4>\n<\/td>\n<td>\n<h4><strong>Session 3:    Development and Stem Cells<\/strong><\/h4>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td align=\"right\">1:05<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">1:15 PM<\/td>\n<td><strong> <\/strong>Moderator Introduction<\/td>\n<td>Joyce Bischoff<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">1:15<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">1:40 PM<\/td>\n<td><strong> <\/strong>Regulation of angiogenesis by vascular suppressor genes<\/td>\n<td>Joann Chan<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">1:40<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">2:05 PM<\/td>\n<td><strong> <\/strong>Vascular Production of BMP2 and its Role During Postnatal Bone Repair<\/td>\n<td>Louis Gerstenfeld<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">2:05<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">2:30 PM<\/td>\n<td><strong> <\/strong>Reciprocal signaling between semaphorin and VEGF shapes the vascular topology<\/td>\n<td>Chenghua Gu<\/td>\n<\/tr>\n<tr>\n<td align=\"right\"><\/td>\n<td><\/td>\n<td align=\"right\"><\/td>\n<td><strong> <\/strong><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td align=\"right\">\n<h4>2:30<\/h4>\n<\/td>\n<td>\n<h4>\u2013<\/h4>\n<\/td>\n<td align=\"right\">\n<h4>2:50 PM<\/h4>\n<\/td>\n<td>\n<h4><em><strong>BREAK<\/strong><\/em><\/h4>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td align=\"right\">\n<h4>2:50<\/h4>\n<\/td>\n<td>\n<h4>\u2013<\/h4>\n<\/td>\n<td align=\"right\">\n<h4>4:00 PM<\/h4>\n<\/td>\n<td>\n<h4><strong>Session 4:    Therapeutic Angiogenesis<\/strong><\/h4>\n<\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td align=\"right\">2:50<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">3:00 PM<\/td>\n<td>Moderator Introduction<\/td>\n<td>Rakesh Jain<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">3:00<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">3:30 PM<\/td>\n<td><strong> <\/strong>Material-based delivery of cells and factors<\/td>\n<td>David Mooney<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">3:30<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">3:45 PM<\/td>\n<td><strong> <\/strong>Endothelial cell control of cancer biology<\/td>\n<td>Juliana Dreyfuss<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">3:45<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">4:00 PM<\/td>\n<td><strong> <\/strong>Tumor interstitial matrix targeting and drug delivery<\/td>\n<td>Yves Boucher<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">4:00<\/td>\n<td>\u2013<\/td>\n<td align=\"right\">4:05 PM<\/td>\n<td>Keynote Introduction<\/td>\n<td>Matt Nugent<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">\n<h4>4:05<\/h4>\n<\/td>\n<td>\n<h4>\u2013<\/h4>\n<\/td>\n<td align=\"right\">\n<h4>5:00 PM<\/h4>\n<\/td>\n<td>\n<h4><strong>Keynote Lecture: <\/strong><\/h4>\n<h4><strong>Microvascular Pericytes: Integrators of Angiogenic Activation<\/strong><\/h4>\n<\/td>\n<td>Ira Herman<\/td>\n<\/tr>\n<tr>\n<td align=\"right\">\n<h4>5:00<\/h4>\n<\/td>\n<td>\n<h4>\u2013<\/h4>\n<\/td>\n<td align=\"right\">\n<h4>6:00 PM<\/h4>\n<\/td>\n<td>\n<h4><strong><em>RECEPTION<\/em><\/strong><\/h4>\n<\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Agenda 14th Annual Boston Angiogenesis Meeting Meeting Chair: Matthew A. Nugent 8:00 \u2013 8:45 AM Registration 8:45 \u2013 8:55 AM Introduction Matt Nugent 8:55 \u2013 10:35 AM Session 1: Molecular Mechanisms 8:55 \u2013 9:05 AM Moderator Introduction Nader Rahimi 9:05 \u2013 9:35 AM Regulation of angiogenesis and tumor growth by thrombospondin-1 Jack Lawler 9:35 \u2013 [&hellip;]<\/p>\n","protected":false},"author":6152,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"page-templates\/no-sidebars.php","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/bam2012\/wp-json\/wp\/v2\/pages\/23"}],"collection":[{"href":"https:\/\/www.bu.edu\/bam2012\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/bam2012\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/bam2012\/wp-json\/wp\/v2\/users\/6152"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/bam2012\/wp-json\/wp\/v2\/comments?post=23"}],"version-history":[{"count":30,"href":"https:\/\/www.bu.edu\/bam2012\/wp-json\/wp\/v2\/pages\/23\/revisions"}],"predecessor-version":[{"id":43,"href":"https:\/\/www.bu.edu\/bam2012\/wp-json\/wp\/v2\/pages\/23\/revisions\/43"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/bam2012\/wp-json\/wp\/v2\/media?parent=23"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}